INS and Alzheimer disease: To overcome this metabolic bottleneck, several clinical trials of insulin and insulin-related drugs have been performed in subjects with MCI/AD to understand the impact of insulin signaling in the brain and assess the efficacy of diabetes drugs for the treatment of neurodegenerative disorders.